Halozyme Therapeutics (HALO) Q2 2015 Earnings

11MayConfirmed
Q3 2014
Q4 2014
Q1 2015
Q2 2015
-0.16
-0.12
-0.07
-0.03

Details

Expected EPS
-0.14
Actual EPS
-0.12
Surprise EPS
0.02
Surprise Percent
+14.29%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.12 per share for Q2 2015.

0 Comments

Share your thoughts